Facility Evaluation Report

Licensing Program Analyst (LPA) Cuadra conducted a case management visit to cite deficiencies discovered during a complaint investigation and met with Administrator, Jamie Healer.

LPA learned through records review that on 8/13/25 resident (R1) was relocated to another facility, where it was discovered during a spot check of medications that Tranexamic Acid prescribed by R1’s neurosurgeon on 6/28/25 was not continued because the medication was not refilled by the facility until the day of them moving out, then the facility disclosed having difficulty getting the medication, which it was confirmed during records review that the facility provided Tranexamic Acid 650mg, from 6/28/25 to 7/31/25, but dates from 8/1/25 through 8/12/25 medication was not available due to prior authorization needed as a reason why the medication was not given as prescribed. Although, on 8/8/25 at 2:06:01pm a fax was sent to R1’s primary physician requesting Tranexamic Acid 650 mg to be filled by neurosurgeon due to the prescription was needed to be filled because resident was out of medication and refill. A second fax was successfully received on 8/11/25 at 1:59:49pm from physician authorizing the medication with a written note indicating staff to pick up at Kaiser. However, R1 left the facility on 8/13/25 without their prescribed medication.

Deficiencies cited from the California Code of Regulations, Title 22, Division 6 of California Regulation. Appeal rights given. Failure to correct the deficiency and/or repeat deficiencies within a 12-month period may result in civil penalties